MRC Biosafety Cabinet Evaluation

AMENDMENT 01 FDA issues the subject Amendment 01 incorporating all questions and answers submitted in response to the RFQ, and extending the quote deadline. Please review in its entirety.

Quotation Deadline: The deadline for receipt of quotations in response to this requirement is extended to Wednesday, January 8, 2025, at 12:00pm ET. Quote submissions are to be submitted to the CO using subject line “75F40125Q00050 – CVM Evaluation of Biological Safety Cabinets”. Quoters shall not submit electronic documents using Microsoft Office Suite products that contain the use of “macros”.

ORIGINAL SOLICITATION SEE ATTACHED SOLICITATION IMPORTANT DATES AND INFORMATION I. Mandatory Site Visit: All Quoters must attend at no cost to the Government, a Site Survey:

When: Tuesday, December 17, 2024, from 10:00am to 12:00pm ET.

Where: US Food and Drug Administration, Muirkirk Research Complex in Laurel, Maryland. Firms are to arrive no later than 9:30am ET. The Quoter must electronically provide to the Contracting Officer (CO), Sheneil Green at Sheneil.Green@fda.hhs.gov no later than 9:00am, December 16, 2024, the below information. All attendees must have a valid Government issued ID: Full name and telephone number of individual attendees Company Name, address, and telephone number. The CO will provide the specific site visit location and point of contact information via confirmation email. II.

Question Deadline: Thursday, December 19, 2024, at 12:00pm ET. Questions related to this procurement shall be submitted via email to CO at sheneil.green@fda.hhs.gov. No phone calls will be accepted. Questions received after the deadline will not be considered. Responses will be posted to SAM.gov. III.

Quotation Deadline: The deadline for receipt of quotations in response to this requirement is Tuesday, December 24, 2024, at 12:00pm ET. Quote submissions are to be submitted to the CO using subject line “75F40125Q00050 – CVM Evaluation of Biological Safety Cabinets”. Quoters shall not submit electronic documents using Microsoft Office Suite products that contain the use of “macros”.